Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ademetionine in Intrahepatic Cholestasis with Alcoholic Liver Disease
NCT02200029Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Jun 2014
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ademetionine butanedisulfonate in Intrahepatic cholestasis (ICP), sponsored by Abbott Laboratories. Started Jun 2014; status: completed.
02
Drugs
ademetionine butanedisulfonate
03
Conditions
Intrahepatic cholestasis (ICP)
Beyond the preview
Go deeper on NCT02200029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02200029.